384 related articles for article (PubMed ID: 32442317)
1. The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome.
Tamimi F; Abusamak M; Akkanti B; Chen Z; Yoo SH; Karmouty-Quintana H
Br J Pharmacol; 2020 Nov; 177(21):4845-4850. PubMed ID: 32442317
[TBL] [Abstract][Full Text] [Related]
2. A rationale for targeting the P2X7 receptor in Coronavirus disease 19.
Di Virgilio F; Tang Y; Sarti AC; Rossato M
Br J Pharmacol; 2020 Nov; 177(21):4990-4994. PubMed ID: 32441783
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19.
Robb CT; Goepp M; Rossi AG; Yao C
Br J Pharmacol; 2020 Nov; 177(21):4899-4920. PubMed ID: 32700336
[TBL] [Abstract][Full Text] [Related]
4. The COVID-19 Cytokine Storm; What We Know So Far.
Ragab D; Salah Eldin H; Taeimah M; Khattab R; Salem R
Front Immunol; 2020; 11():1446. PubMed ID: 32612617
[TBL] [Abstract][Full Text] [Related]
5. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
6. Statins: Could an old friend help in the fight against COVID-19?
Rodrigues-Diez RR; Tejera-Muñoz A; Marquez-Exposito L; Rayego-Mateos S; Santos Sanchez L; Marchant V; Tejedor Santamaria L; Ramos AM; Ortiz A; Egido J; Ruiz-Ortega M
Br J Pharmacol; 2020 Nov; 177(21):4873-4886. PubMed ID: 32562276
[TBL] [Abstract][Full Text] [Related]
7. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".
Castelli V; Cimini A; Ferri C
Front Immunol; 2020; 11():2132. PubMed ID: 32983172
[TBL] [Abstract][Full Text] [Related]
8. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology.
Cleary SJ; Pitchford SC; Amison RT; Carrington R; Robaina Cabrera CL; Magnen M; Looney MR; Gray E; Page CP
Br J Pharmacol; 2020 Nov; 177(21):4851-4865. PubMed ID: 32462701
[TBL] [Abstract][Full Text] [Related]
9. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
[TBL] [Abstract][Full Text] [Related]
10. The potential of cannabidiol in the COVID-19 pandemic.
Esposito G; Pesce M; Seguella L; Sanseverino W; Lu J; Corpetti C; Sarnelli G
Br J Pharmacol; 2020 Nov; 177(21):4967-4970. PubMed ID: 32519753
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19.
Moutsopoulos HM
Ann Rheum Dis; 2020 Sep; 79(9):1253-1254. PubMed ID: 32345616
[No Abstract] [Full Text] [Related]
12. Rationale for targeting complement in COVID-19.
Polycarpou A; Howard M; Farrar CA; Greenlaw R; Fanelli G; Wallis R; Klavinskis LS; Sacks S
EMBO Mol Med; 2020 Aug; 12(8):e12642. PubMed ID: 32559343
[TBL] [Abstract][Full Text] [Related]
13. Targeting the NLRP3 Inflammasome in Severe COVID-19.
Freeman TL; Swartz TH
Front Immunol; 2020; 11():1518. PubMed ID: 32655582
[TBL] [Abstract][Full Text] [Related]
14. Targeting zinc metalloenzymes in coronavirus disease 2019.
Doboszewska U; Wlaź P; Nowak G; Młyniec K
Br J Pharmacol; 2020 Nov; 177(21):4887-4898. PubMed ID: 32671829
[TBL] [Abstract][Full Text] [Related]
15. The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: Lessons for drug repurposing.
Bertocchi I; Foglietta F; Collotta D; Eva C; Brancaleone V; Thiemermann C; Collino M
Br J Pharmacol; 2020 Nov; 177(21):4921-4930. PubMed ID: 32776354
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H
Citi V; Martelli A; Brancaleone V; Brogi S; Gojon G; Montanaro R; Morales G; Testai L; Calderone V
Br J Pharmacol; 2020 Nov; 177(21):4931-4941. PubMed ID: 32783196
[TBL] [Abstract][Full Text] [Related]
17. Tackling the cytokine storm in COVID-19, challenges and hopes.
Abdin SM; Elgendy SM; Alyammahi SK; Alhamad DW; Omar HA
Life Sci; 2020 Sep; 257():118054. PubMed ID: 32663575
[TBL] [Abstract][Full Text] [Related]
18.
Siddiqui R; Khan NA
ACS Chem Neurosci; 2020 Aug; 11(16):2391-2392. PubMed ID: 32786329
[TBL] [Abstract][Full Text] [Related]
19. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
20. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
